MedPlus Health Services Limited disclosed that its subsidiary Optival Health Solutions Private Limited received a 25-day drug license suspension order from Maharashtra's Food & Drug Administration for a store in Bhandara. The suspension, imposed under Rule 65 of Drugs and Cosmetics Act, 1940, carries a potential revenue loss of Rs 7.53 lacs. The company made this disclosure under SEBI listing regulations, with the order received on January 30, 2026.
MedPlus Health Services Subsidiary Faces 25-Day Drug License Suspension in Maharashtra
